Neuronetics (STIM) News Today $4.13 -0.67 (-13.96%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$4.18 +0.04 (+1.09%) As of 02/21/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference CallFebruary 21 at 5:24 PM | markets.businessinsider.comInsider Selling: Neuronetics, Inc. (NASDAQ:STIM) CFO Sells 17,307 Shares of StockNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) CFO Stephen Furlong sold 17,307 shares of the firm's stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $4.11, for a total value of $71,131.77. Following the completion of the transaction, the chief financial officer now owns 454,420 shares in the company, valued at approximately $1,867,666.20. This trade represents a 3.67 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.February 19 at 5:16 PM | marketbeat.comStephen Furlong Sells 17,307 Shares of Neuronetics, Inc. (NASDAQ:STIM) StockFebruary 19 at 4:49 AM | insidertrades.comInsider Selling: Neuronetics, Inc. (NASDAQ:STIM) CFO Sells 10,845 Shares of StockNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) CFO Stephen Furlong sold 10,845 shares of the stock in a transaction on Wednesday, February 12th. The shares were sold at an average price of $3.83, for a total transaction of $41,536.35. Following the transaction, the chief financial officer now owns 471,727 shares of the company's stock, valued at $1,806,714.41. This trade represents a 2.25 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.February 15, 2025 | marketbeat.comNeuronetics, Inc. (NASDAQ:STIM) EVP Sells $46,630.25 in StockNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) EVP William Andrew Macan sold 12,175 shares of the company's stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of $3.83, for a total value of $46,630.25. Following the sale, the executive vice president now owns 388,647 shares of the company's stock, valued at $1,488,518.01. The trade was a 3.04 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.February 15, 2025 | marketbeat.comNeuronetics, Inc. (NASDAQ:STIM) CFO Stephen Furlong Sells 10,845 SharesFebruary 15, 2025 | insidertrades.comNeuronetics EVP William Andrew Macan sells $46,630 in stockFebruary 14, 2025 | msn.comNeuronetics CFO Stephen Furlong sells $41,536 in stockFebruary 14, 2025 | msn.comNeuronetics CFO Stephen Furlong sells shares worth $48,662February 13, 2025 | msn.comNeuronetics, Inc. (NASDAQ:STIM) CFO Stephen Furlong Sells 14,836 SharesFebruary 13, 2025 | insidertrades.comNeuronetics' EVP William Andrew Macan sells $6,461 in stockFebruary 13, 2025 | msn.comNeuronetics CEO Keith Sullivan sells $134,453 in stockFebruary 13, 2025 | msn.comStephen Furlong Sells 14,836 Shares of Neuronetics, Inc. (NASDAQ:STIM) StockNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) CFO Stephen Furlong sold 14,836 shares of the firm's stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $3.28, for a total transaction of $48,662.08. Following the completion of the transaction, the chief financial officer now directly owns 482,572 shares in the company, valued at approximately $1,582,836.16. The trade was a 2.98 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.February 12, 2025 | marketbeat.comInsider Selling: Neuronetics, Inc. (NASDAQ:STIM) CEO Sells 40,992 Shares of StockNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) CEO Keith J. Sullivan sold 40,992 shares of the firm's stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $3.28, for a total transaction of $134,453.76. Following the completion of the sale, the chief executive officer now owns 1,283,362 shares of the company's stock, valued at $4,209,427.36. This trade represents a 3.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.February 12, 2025 | marketbeat.comNews Flash: Analysts Just Made A Stunning Upgrade To Their Neuronetics, Inc. (NASDAQ:STIM) ForecastsFebruary 11, 2025 | finance.yahoo.comNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)February 7, 2025 | globenewswire.comNeuronetics Shares Drop After $18M Offering PricedFebruary 7, 2025 | marketwatch.comNeuronetics prices 8M shares at $2.25 in underwritten public offeringFebruary 7, 2025 | markets.businessinsider.comNeuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common StockFebruary 7, 2025 | finance.yahoo.comNeuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common StockFebruary 7, 2025 | globenewswire.comNeuronetics announces public stock offeringFebruary 6, 2025 | msn.comNeuronetics announces common stock offering, no amount givenFebruary 6, 2025 | markets.businessinsider.comNeuronetics Announces Launch of Underwritten Public Offering of Common StockFebruary 6, 2025 | globenewswire.comWhy Neuronetics Inc (STIM) Is Skyrocketing So Far In 2025February 3, 2025 | msn.comNeuroStar Unveils Two Significant Publications on TMS Therapy for DepressionJanuary 29, 2025 | globenewswire.comNeuronetics (NASDAQ:STIM) shareholders are up 34% this past week, but still in the red over the last five yearsJanuary 29, 2025 | finance.yahoo.comNeuronetics, Inc. (NASDAQ:STIM) Short Interest UpdateNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) was the recipient of a significant drop in short interest during the month of January. As of January 15th, there was short interest totalling 312,900 shares, a drop of 35.8% from the December 31st total of 487,400 shares. Currently, 2.0% of the shares of the company are short sold. Based on an average trading volume of 413,300 shares, the short-interest ratio is presently 0.8 days.January 29, 2025 | marketbeat.comNeuronetics’ Strong Financial Performance and Strategic Outlook Boosts Buy RatingJanuary 15, 2025 | markets.businessinsider.comNeuronetics, Inc. (NASDAQ:STIM) Sees Significant Drop in Short InterestNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) was the recipient of a significant decline in short interest in the month of December. As of December 31st, there was short interest totalling 312,900 shares, a decline of 35.8% from the December 15th total of 487,400 shares. Currently, 2.0% of the shares of the stock are sold short. Based on an average trading volume of 413,300 shares, the short-interest ratio is presently 0.8 days.January 14, 2025 | marketbeat.comNeuronetics sees FY25 revenue $145M-$155MJanuary 13, 2025 | markets.businessinsider.comNeuronetics Awards Stock Units to New Employee Bill LeonardDecember 20, 2024 | msn.comNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)December 18, 2024 | globenewswire.comNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)December 16, 2024 | globenewswire.comNeuronetics and Greenbrook TMS Announce Closing of TransactionDecember 10, 2024 | globenewswire.comNeuronetics to Showcase Neurohealth Innovations at Piper Sandler Healthcare Conference!November 22, 2024 | msn.comNeuronetics to Present at the Piper Sandler 36th Annual Healthcare ConferenceNovember 20, 2024 | globenewswire.comNeuronetics, Inc. (NASDAQ:STIM) Analysts Are Cutting Their Estimates: Here's What You Need To KnowNovember 15, 2024 | finance.yahoo.comNeuronetics Faces Nasdaq Delisting Risk: Can It Meet the $1.00 Bid Price Requirement?November 14, 2024 | markets.businessinsider.comNeuronetics Grants Inducement Awards to New EmployeesNovember 14, 2024 | msn.comNeuronetics, Inc. (STIM) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | seekingalpha.comCORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating ResultsNovember 12, 2024 | globenewswire.comNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)November 12, 2024 | globenewswire.comNeuronetics Reports Record Third Quarter 2024 Financial and Operating ResultsNovember 12, 2024 | globenewswire.comNeuronetics Inc (STIM) Q3 2024 Earnings Report Preview: What to ExpectNovember 11, 2024 | finance.yahoo.comNeuronetics to Unveil Q3 2024 Financial ResultsOctober 31, 2024 | msn.comNeuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference CallOctober 29, 2024 | globenewswire.comNeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with DepressionOctober 14, 2024 | globenewswire.comNeuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder MeetingsOctober 4, 2024 | prnewswire.comBrainsWay: More Cash, More UncertaintyOctober 1, 2024 | seekingalpha.comNeuronetics Expands TMS Access for Adolescents with DepressionSeptember 27, 2024 | msn.com Get Neuronetics News Delivered to You Automatically Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter. Email Address STIM Media Mentions By Week STIM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. STIM News Sentiment▼0.530.60▲Average Medical News Sentiment STIM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. STIM Articles This Week▼73▲STIM Articles Average Week Get Neuronetics News Delivered to You Automatically Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DCTH News Today CLPT News Today SMLR News Today TCMD News Today NNOX News Today NPCE News Today CVRX News Today ZIMV News Today NYXH News Today SMTI News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:STIM) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuronetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuronetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free STIM Stock Alerts